SkinHealth Systems Inc. 8-K

What Happened
SkinHealth Systems Inc. (Nasdaq: SKIN) filed an 8-K (Item 3.01) reporting that Nasdaq notified the company that its Class A common stock failed to meet Nasdaq Listing Rule 5550(a)(2) because the closing bid price was below $1.00 for 30 consecutive business days (March 26, 2026 through May 7, 2026). The Notice does not affect current listing or trading, and SKIN will continue trading on Nasdaq while pursuing compliance.

Key Details

• Nasdaq found the closing bid price < $1.00 for 30 consecutive business days (Mar 26, 2026–May 7, 2026).
• Company has a 180-calendar-day Compliance Period to regain compliance — deadline: November 4, 2026. To cure, the closing bid must be ≥ $1.00 for at least 10 consecutive business days (Nasdaq may require up to ~20 days).
• If still noncompliant, SkinHealth may request an additional 180-day period only if it meets market value and other initial listing standards (may require a reverse stock split); otherwise Nasdaq may move to delist.
• If delisting is initiated, the company can appeal to a Nasdaq Hearings Panel. The company says it will monitor the share price and consider options but gives no assurance it will regain compliance.

Why It Matters
For retail investors, a Nasdaq minimum bid notice is a warning that the stock could be at risk of delisting if the company doesn’t restore its share price. Continued Nasdaq listing affects liquidity, visibility, and potentially the willingness of institutions and brokers to hold or recommend the stock. SkinHealth’s shareholders should watch the stock’s closing price, any company actions (e.g., reverse stock split), and follow further filings or Nasdaq notices for updates. The filing also contains forward-looking statements about the company’s plans and uncertainty about achieving compliance.